Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

May 21, 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

May 15, 2024

Debate Continues on TAVI Choice for Women With Small Annuli

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

May 27, 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

May 18, 2022

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.